BioAtla (BCAB) Cash & Equivalents (2020 - 2026)
BioAtla's Cash & Equivalents was $1.54 million in Q2 2026, down 91.5% from $18.21 million a year earlier and down 21.3% from the prior quarter.
Powered by 
Analysis
BioAtla (BCAB) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at BioAtla came in at $7.12 million, down 85.5% from FY2024.
- Cash & Equivalents has now declined for four consecutive years, with a five-year compound annual growth rate of -50.5% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $49.05 million in FY2024 (-56.0%), $111.47 million in FY2023 (-48.3%), $215.51 million in FY2022 (-12.0%) and $244.98 million in FY2021 (+2.7%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q2 2020.
- Compared with a year earlier, Cash & Equivalents has declined for 18 straight quarters, with an average decline of 75.3% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2021 (growth of 375.6%); the worst was Q1 2026 (a decline of 93.9%).
- Per Business Quant data, BCAB's Cash & Equivalents in the three quarters before Q2 2026 was $1.96 million (Q1 2026), $7.12 million (Q4 2025) and $8.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | BioAtla | 2.25 Mn | 2.25 Mn | - | 1.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.54 Mn |
| Mar 31, 2026 | 1.96 Mn |
| Dec 31, 2025 | 7.12 Mn |
| Sep 30, 2025 | 8.32 Mn |
| Jun 30, 2025 | 18.21 Mn |
| Mar 31, 2025 | 32.36 Mn |
| Dec 31, 2024 | 49.05 Mn |
| Sep 30, 2024 | 56.52 Mn |
| Jun 30, 2024 | 61.66 Mn |
| Mar 31, 2024 | 80.63 Mn |
| Dec 31, 2023 | 111.47 Mn |
| Sep 30, 2023 | 141.28 Mn |
| Jun 30, 2023 | 168.69 Mn |
| Mar 31, 2023 | 192.69 Mn |
| Dec 31, 2022 | 215.51 Mn |
| Sep 30, 2022 | 178.12 Mn |
| Jun 30, 2022 | 202.29 Mn |
| Mar 31, 2022 | 219.43 Mn |
| Dec 31, 2021 | 244.98 Mn |
| Sep 30, 2021 | 269.93 Mn |
API Access
BioAtla Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BCAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BCAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BCAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();